English
简体中文
Total: £ 56.28
Published Date: 2025-05-21 | Pages: 91 | Tables: 95 | Medical Care
The global market for Transplant Molecular Diagnostic was valued at US$ 2627 million in the year 2024 and is projected to reach a revised size of US$ 4274 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Transplant molecular diagnostic is a specialized field within the broader domain of medical diagnostics that focuses on the use of molecular techniques to assess various aspects related to organ or tissue transplantation. It involves the detection and analysis of genetic, epigenetic, and molecular markers in both donors and recipients. These markers can provide crucial information about the compatibility between the donor and recipient, the risk of rejection, the presence of infectious agents, and the overall prognosis of the transplant. By leveraging advanced molecular technologies such as polymerase chain reaction (PCR), next - generation sequencing (NGS), and gene expression profiling, transplant molecular diagnostic enables more accurate and personalized decision - making in the transplant process, ultimately improving the success rate and long - term outcomes of transplantation.
North American market for Transplant Molecular Diagnostic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Transplant Molecular Diagnostic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Transplant Molecular Diagnostic in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Transplant Molecular Diagnostic include Abbott, Bio-Rad Laboratories, QIAGEN N.V., Bruker Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Becton, Dickinson and Company, QuidelOrtho Corporation, bioMérieux, Illumina, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transplant Molecular Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transplant Molecular Diagnostic.
The Transplant Molecular Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transplant Molecular Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transplant Molecular Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Bio-Rad Laboratories
QIAGEN N.V.
Bruker Corporation
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific
Becton, Dickinson and Company
QuidelOrtho Corporation
bioMérieux
Illumina
Siemens Healthineers
Agilent Technologies
Takara Bio Inc.
Hologic
Werfen
DiaSorin
Segment by Type
Instruments
Kits and Reagents
Software and Services
Segment by Application
Hospitals
Transplant Centers
Research Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transplant Molecular Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transplant Molecular Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instruments
1.2.3 Kits and Reagents
1.2.4 Software and Services
1.3 Market by Application
1.3.1 Global Transplant Molecular Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Transplant Centers
1.3.4 Research Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transplant Molecular Diagnostic Market Perspective (2020-2031)
2.2 Global Transplant Molecular Diagnostic Growth Trends by Region
2.2.1 Global Transplant Molecular Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transplant Molecular Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Transplant Molecular Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Transplant Molecular Diagnostic Market Dynamics
2.3.1 Transplant Molecular Diagnostic Industry Trends
2.3.2 Transplant Molecular Diagnostic Market Drivers
2.3.3 Transplant Molecular Diagnostic Market Challenges
2.3.4 Transplant Molecular Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transplant Molecular Diagnostic Players by Revenue
3.1.1 Global Top Transplant Molecular Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Transplant Molecular Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Top Transplant Molecular Diagnostic Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transplant Molecular Diagnostic Revenue
3.4 Global Transplant Molecular Diagnostic Market Concentration Ratio
3.4.1 Global Transplant Molecular Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transplant Molecular Diagnostic Revenue in 2024
3.5 Global Key Players of Transplant Molecular Diagnostic Head office and Area Served
3.6 Global Key Players of Transplant Molecular Diagnostic, Product and Application
3.7 Global Key Players of Transplant Molecular Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transplant Molecular Diagnostic Breakdown Data by Type
4.1 Global Transplant Molecular Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Transplant Molecular Diagnostic Forecasted Market Size by Type (2026-2031)
5 Transplant Molecular Diagnostic Breakdown Data by Application
5.1 Global Transplant Molecular Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Transplant Molecular Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transplant Molecular Diagnostic Market Size (2020-2031)
6.2 North America Transplant Molecular Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transplant Molecular Diagnostic Market Size by Country (2020-2025)
6.4 North America Transplant Molecular Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transplant Molecular Diagnostic Market Size (2020-2031)
7.2 Europe Transplant Molecular Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transplant Molecular Diagnostic Market Size by Country (2020-2025)
7.4 Europe Transplant Molecular Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transplant Molecular Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Transplant Molecular Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transplant Molecular Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Transplant Molecular Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transplant Molecular Diagnostic Market Size (2020-2031)
9.2 Latin America Transplant Molecular Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transplant Molecular Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Transplant Molecular Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transplant Molecular Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Transplant Molecular Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transplant Molecular Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Transplant Molecular Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Transplant Molecular Diagnostic Introduction
11.1.4 Abbott Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Transplant Molecular Diagnostic Introduction
11.2.4 Bio-Rad Laboratories Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 QIAGEN N.V.
11.3.1 QIAGEN N.V. Company Details
11.3.2 QIAGEN N.V. Business Overview
11.3.3 QIAGEN N.V. Transplant Molecular Diagnostic Introduction
11.3.4 QIAGEN N.V. Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.3.5 QIAGEN N.V. Recent Development
11.4 Bruker Corporation
11.4.1 Bruker Corporation Company Details
11.4.2 Bruker Corporation Business Overview
11.4.3 Bruker Corporation Transplant Molecular Diagnostic Introduction
11.4.4 Bruker Corporation Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.4.5 Bruker Corporation Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Transplant Molecular Diagnostic Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Transplant Molecular Diagnostic Introduction
11.6.4 Thermo Fisher Scientific Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Becton, Dickinson and Company
11.7.1 Becton, Dickinson and Company Company Details
11.7.2 Becton, Dickinson and Company Business Overview
11.7.3 Becton, Dickinson and Company Transplant Molecular Diagnostic Introduction
11.7.4 Becton, Dickinson and Company Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.7.5 Becton, Dickinson and Company Recent Development
11.8 QuidelOrtho Corporation
11.8.1 QuidelOrtho Corporation Company Details
11.8.2 QuidelOrtho Corporation Business Overview
11.8.3 QuidelOrtho Corporation Transplant Molecular Diagnostic Introduction
11.8.4 QuidelOrtho Corporation Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.8.5 QuidelOrtho Corporation Recent Development
11.9 bioMérieux
11.9.1 bioMérieux Company Details
11.9.2 bioMérieux Business Overview
11.9.3 bioMérieux Transplant Molecular Diagnostic Introduction
11.9.4 bioMérieux Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.9.5 bioMérieux Recent Development
11.10 Illumina
11.10.1 Illumina Company Details
11.10.2 Illumina Business Overview
11.10.3 Illumina Transplant Molecular Diagnostic Introduction
11.10.4 Illumina Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.10.5 Illumina Recent Development
11.11 Siemens Healthineers
11.11.1 Siemens Healthineers Company Details
11.11.2 Siemens Healthineers Business Overview
11.11.3 Siemens Healthineers Transplant Molecular Diagnostic Introduction
11.11.4 Siemens Healthineers Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.11.5 Siemens Healthineers Recent Development
11.12 Agilent Technologies
11.12.1 Agilent Technologies Company Details
11.12.2 Agilent Technologies Business Overview
11.12.3 Agilent Technologies Transplant Molecular Diagnostic Introduction
11.12.4 Agilent Technologies Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.12.5 Agilent Technologies Recent Development
11.13 Takara Bio Inc.
11.13.1 Takara Bio Inc. Company Details
11.13.2 Takara Bio Inc. Business Overview
11.13.3 Takara Bio Inc. Transplant Molecular Diagnostic Introduction
11.13.4 Takara Bio Inc. Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.13.5 Takara Bio Inc. Recent Development
11.14 Hologic
11.14.1 Hologic Company Details
11.14.2 Hologic Business Overview
11.14.3 Hologic Transplant Molecular Diagnostic Introduction
11.14.4 Hologic Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.14.5 Hologic Recent Development
11.15 Werfen
11.15.1 Werfen Company Details
11.15.2 Werfen Business Overview
11.15.3 Werfen Transplant Molecular Diagnostic Introduction
11.15.4 Werfen Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.15.5 Werfen Recent Development
11.16 DiaSorin
11.16.1 DiaSorin Company Details
11.16.2 DiaSorin Business Overview
11.16.3 DiaSorin Transplant Molecular Diagnostic Introduction
11.16.4 DiaSorin Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.16.5 DiaSorin Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Transplant Molecular Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Instruments
Table 3. Key Players of Kits and Reagents
Table 4. Key Players of Software and Services
Table 5. Global Transplant Molecular Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Transplant Molecular Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Transplant Molecular Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Transplant Molecular Diagnostic Market Share by Region (2020-2025)
Table 9. Global Transplant Molecular Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Transplant Molecular Diagnostic Market Share by Region (2026-2031)
Table 11. Transplant Molecular Diagnostic Market Trends
Table 12. Transplant Molecular Diagnostic Market Drivers
Table 13. Transplant Molecular Diagnostic Market Challenges
Table 14. Transplant Molecular Diagnostic Market Restraints
Table 15. Global Transplant Molecular Diagnostic Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Transplant Molecular Diagnostic Market Share by Players (2020-2025)
Table 17. Global Top Transplant Molecular Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transplant Molecular Diagnostic as of 2024)
Table 18. Ranking of Global Top Transplant Molecular Diagnostic Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Transplant Molecular Diagnostic Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Transplant Molecular Diagnostic, Headquarters and Area Served
Table 21. Global Key Players of Transplant Molecular Diagnostic, Product and Application
Table 22. Global Key Players of Transplant Molecular Diagnostic, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Transplant Molecular Diagnostic Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Transplant Molecular Diagnostic Revenue Market Share by Type (2020-2025)
Table 26. Global Transplant Molecular Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Transplant Molecular Diagnostic Revenue Market Share by Type (2026-2031)
Table 28. Global Transplant Molecular Diagnostic Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Transplant Molecular Diagnostic Revenue Market Share by Application (2020-2025)
Table 30. Global Transplant Molecular Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Transplant Molecular Diagnostic Revenue Market Share by Application (2026-2031)
Table 32. North America Transplant Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Transplant Molecular Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Transplant Molecular Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Transplant Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Transplant Molecular Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Transplant Molecular Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Transplant Molecular Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Transplant Molecular Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Transplant Molecular Diagnostic Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Transplant Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Transplant Molecular Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Transplant Molecular Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Transplant Molecular Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Transplant Molecular Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Transplant Molecular Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abbott Company Details
Table 48. Abbott Business Overview
Table 49. Abbott Transplant Molecular Diagnostic Product
Table 50. Abbott Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. Bio-Rad Laboratories Company Details
Table 53. Bio-Rad Laboratories Business Overview
Table 54. Bio-Rad Laboratories Transplant Molecular Diagnostic Product
Table 55. Bio-Rad Laboratories Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 56. Bio-Rad Laboratories Recent Development
Table 57. QIAGEN N.V. Company Details
Table 58. QIAGEN N.V. Business Overview
Table 59. QIAGEN N.V. Transplant Molecular Diagnostic Product
Table 60. QIAGEN N.V. Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 61. QIAGEN N.V. Recent Development
Table 62. Bruker Corporation Company Details
Table 63. Bruker Corporation Business Overview
Table 64. Bruker Corporation Transplant Molecular Diagnostic Product
Table 65. Bruker Corporation Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 66. Bruker Corporation Recent Development
Table 67. F. Hoffmann-La Roche Ltd. Company Details
Table 68. F. Hoffmann-La Roche Ltd. Business Overview
Table 69. F. Hoffmann-La Roche Ltd. Transplant Molecular Diagnostic Product
Table 70. F. Hoffmann-La Roche Ltd. Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 71. F. Hoffmann-La Roche Ltd. Recent Development
Table 72. Thermo Fisher Scientific Company Details
Table 73. Thermo Fisher Scientific Business Overview
Table 74. Thermo Fisher Scientific Transplant Molecular Diagnostic Product
Table 75. Thermo Fisher Scientific Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 76. Thermo Fisher Scientific Recent Development
Table 77. Becton, Dickinson and Company Company Details
Table 78. Becton, Dickinson and Company Business Overview
Table 79. Becton, Dickinson and Company Transplant Molecular Diagnostic Product
Table 80. Becton, Dickinson and Company Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 81. Becton, Dickinson and Company Recent Development
Table 82. QuidelOrtho Corporation Company Details
Table 83. QuidelOrtho Corporation Business Overview
Table 84. QuidelOrtho Corporation Transplant Molecular Diagnostic Product
Table 85. QuidelOrtho Corporation Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 86. QuidelOrtho Corporation Recent Development
Table 87. bioMérieux Company Details
Table 88. bioMérieux Business Overview
Table 89. bioMérieux Transplant Molecular Diagnostic Product
Table 90. bioMérieux Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 91. bioMérieux Recent Development
Table 92. Illumina Company Details
Table 93. Illumina Business Overview
Table 94. Illumina Transplant Molecular Diagnostic Product
Table 95. Illumina Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 96. Illumina Recent Development
Table 97. Siemens Healthineers Company Details
Table 98. Siemens Healthineers Business Overview
Table 99. Siemens Healthineers Transplant Molecular Diagnostic Product
Table 100. Siemens Healthineers Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 101. Siemens Healthineers Recent Development
Table 102. Agilent Technologies Company Details
Table 103. Agilent Technologies Business Overview
Table 104. Agilent Technologies Transplant Molecular Diagnostic Product
Table 105. Agilent Technologies Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 106. Agilent Technologies Recent Development
Table 107. Takara Bio Inc. Company Details
Table 108. Takara Bio Inc. Business Overview
Table 109. Takara Bio Inc. Transplant Molecular Diagnostic Product
Table 110. Takara Bio Inc. Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 111. Takara Bio Inc. Recent Development
Table 112. Hologic Company Details
Table 113. Hologic Business Overview
Table 114. Hologic Transplant Molecular Diagnostic Product
Table 115. Hologic Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 116. Hologic Recent Development
Table 117. Werfen Company Details
Table 118. Werfen Business Overview
Table 119. Werfen Transplant Molecular Diagnostic Product
Table 120. Werfen Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 121. Werfen Recent Development
Table 122. DiaSorin Company Details
Table 123. DiaSorin Business Overview
Table 124. DiaSorin Transplant Molecular Diagnostic Product
Table 125. DiaSorin Revenue in Transplant Molecular Diagnostic Business (2020-2025) & (US$ Million)
Table 126. DiaSorin Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 130. Authors List of This Report
List of Figures
Figure 1. Transplant Molecular Diagnostic Picture
Figure 2. Global Transplant Molecular Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transplant Molecular Diagnostic Market Share by Type: 2024 VS 2031
Figure 4. Instruments Features
Figure 5. Kits and Reagents Features
Figure 6. Software and Services Features
Figure 7. Global Transplant Molecular Diagnostic Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Transplant Molecular Diagnostic Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Transplant Centers Case Studies
Figure 11. Research Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. Transplant Molecular Diagnostic Report Years Considered
Figure 14. Global Transplant Molecular Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Transplant Molecular Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Transplant Molecular Diagnostic Market Share by Region: 2024 VS 2031
Figure 17. Global Transplant Molecular Diagnostic Market Share by Players in 2024
Figure 18. Global Transplant Molecular Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Transplant Molecular Diagnostic Revenue in 2024
Figure 20. North America Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Transplant Molecular Diagnostic Market Share by Country (2020-2031)
Figure 22. United States Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Transplant Molecular Diagnostic Market Share by Country (2020-2031)
Figure 26. Germany Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Transplant Molecular Diagnostic Market Share by Region (2020-2031)
Figure 34. China Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Transplant Molecular Diagnostic Market Share by Country (2020-2031)
Figure 42. Mexico Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Transplant Molecular Diagnostic Market Share by Country (2020-2031)
Figure 46. Turkey Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Transplant Molecular Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abbott Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 51. QIAGEN N.V. Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 52. Bruker Corporation Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 53. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 55. Becton, Dickinson and Company Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 56. QuidelOrtho Corporation Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 57. bioMérieux Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 58. Illumina Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 59. Siemens Healthineers Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 60. Agilent Technologies Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 61. Takara Bio Inc. Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 62. Hologic Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 63. Werfen Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 64. DiaSorin Revenue Growth Rate in Transplant Molecular Diagnostic Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
